Cargando…

Serum protein signature of coronary artery disease in type 2 diabetes mellitus

BACKGROUND: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers. METHODS: Usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Adela, Ramu, Reddy, Podduturu Naveen Chander, Ghosh, Tarini Shankar, Aggarwal, Suruchi, Yadav, Amit Kumar, Das, Bhabatosh, Banerjee, Sanjay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345069/
https://www.ncbi.nlm.nih.gov/pubmed/30674322
http://dx.doi.org/10.1186/s12967-018-1755-5
_version_ 1783389522012143616
author Adela, Ramu
Reddy, Podduturu Naveen Chander
Ghosh, Tarini Shankar
Aggarwal, Suruchi
Yadav, Amit Kumar
Das, Bhabatosh
Banerjee, Sanjay K.
author_facet Adela, Ramu
Reddy, Podduturu Naveen Chander
Ghosh, Tarini Shankar
Aggarwal, Suruchi
Yadav, Amit Kumar
Das, Bhabatosh
Banerjee, Sanjay K.
author_sort Adela, Ramu
collection PubMed
description BACKGROUND: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers. METHODS: Using sensitive multiplex protein assays, we assessed 46 protein markers including cytokines/chemokines, metabolic hormones, adipokines and apolipoproteins for evaluating different pathophysiological conditions of control, T2DM, CAD and T2DM with CAD patients (T2DM_CAD). Network analysis was performed to create protein-protein interaction networks by using significantly (p < 0.05) altered protein markers in each disease using STRING 10.5 database. We used two supervised analysis methods i.e., between class analysis (BCA) and principal component analysis (PCA) to reveals distinct biomarkers profiles. Further, random forest classification (RF) was used to classify the diseases by the panel of markers. RESULTS: Our two supervised analysis methods BCA and PCA revealed a distinct biomarker profiles and high degree of variability in the marker profiles for T2DM_CAD and CAD. Thereafter, the present study identified multiple potential biomarkers to differentiate T2DM, CAD, and T2DM_CAD patients based on their relative abundance in serum. RF classified T2DM based on the abundance patterns of nine markers i.e., IL-1β, GM-CSF, glucagon, PAI-I, rantes, IP-10, resistin, GIP and Apo-B; CAD by 14 markers i.e., resistin, PDGF-BB, PAI-1, lipocalin-2, leptin, IL-13, eotaxin, GM-CSF, Apo-E, ghrelin, adipsin, GIP, Apo-CII and IP-10; and T2DM _CAD by 12 markers i.e., insulin, resistin, PAI-1, adiponectin, lipocalin-2, GM-CSF, adipsin, leptin, Apo-AII, rantes, IL-6 and ghrelin with respect to the control subjects. Using network analysis, we have identified several cellular network proteins like PTPN1, AKT1, INSR, LEPR, IRS1, IRS2, IL1R2, IL6R, PCSK9 and MYD88, which are responsible for regulating inflammation, insulin resistance, and atherosclerosis. CONCLUSION: We have identified three distinct sets of serum markers for diabetes, CAD and diabetes associated with CAD in Indian patients using nonparametric-based machine learning approach. These multiple marker classifiers may be useful for monitoring progression from a healthy person to T2DM and T2DM to T2DM_CAD. However, these findings need to be further confirmed in the future studies with large number of samples. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1755-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6345069
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63450692019-01-29 Serum protein signature of coronary artery disease in type 2 diabetes mellitus Adela, Ramu Reddy, Podduturu Naveen Chander Ghosh, Tarini Shankar Aggarwal, Suruchi Yadav, Amit Kumar Das, Bhabatosh Banerjee, Sanjay K. J Transl Med Research BACKGROUND: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The purpose of the present study was to discriminate the Indian CAD patients with or without T2DM by using multiple pathophysiological biomarkers. METHODS: Using sensitive multiplex protein assays, we assessed 46 protein markers including cytokines/chemokines, metabolic hormones, adipokines and apolipoproteins for evaluating different pathophysiological conditions of control, T2DM, CAD and T2DM with CAD patients (T2DM_CAD). Network analysis was performed to create protein-protein interaction networks by using significantly (p < 0.05) altered protein markers in each disease using STRING 10.5 database. We used two supervised analysis methods i.e., between class analysis (BCA) and principal component analysis (PCA) to reveals distinct biomarkers profiles. Further, random forest classification (RF) was used to classify the diseases by the panel of markers. RESULTS: Our two supervised analysis methods BCA and PCA revealed a distinct biomarker profiles and high degree of variability in the marker profiles for T2DM_CAD and CAD. Thereafter, the present study identified multiple potential biomarkers to differentiate T2DM, CAD, and T2DM_CAD patients based on their relative abundance in serum. RF classified T2DM based on the abundance patterns of nine markers i.e., IL-1β, GM-CSF, glucagon, PAI-I, rantes, IP-10, resistin, GIP and Apo-B; CAD by 14 markers i.e., resistin, PDGF-BB, PAI-1, lipocalin-2, leptin, IL-13, eotaxin, GM-CSF, Apo-E, ghrelin, adipsin, GIP, Apo-CII and IP-10; and T2DM _CAD by 12 markers i.e., insulin, resistin, PAI-1, adiponectin, lipocalin-2, GM-CSF, adipsin, leptin, Apo-AII, rantes, IL-6 and ghrelin with respect to the control subjects. Using network analysis, we have identified several cellular network proteins like PTPN1, AKT1, INSR, LEPR, IRS1, IRS2, IL1R2, IL6R, PCSK9 and MYD88, which are responsible for regulating inflammation, insulin resistance, and atherosclerosis. CONCLUSION: We have identified three distinct sets of serum markers for diabetes, CAD and diabetes associated with CAD in Indian patients using nonparametric-based machine learning approach. These multiple marker classifiers may be useful for monitoring progression from a healthy person to T2DM and T2DM to T2DM_CAD. However, these findings need to be further confirmed in the future studies with large number of samples. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1755-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-24 /pmc/articles/PMC6345069/ /pubmed/30674322 http://dx.doi.org/10.1186/s12967-018-1755-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Adela, Ramu
Reddy, Podduturu Naveen Chander
Ghosh, Tarini Shankar
Aggarwal, Suruchi
Yadav, Amit Kumar
Das, Bhabatosh
Banerjee, Sanjay K.
Serum protein signature of coronary artery disease in type 2 diabetes mellitus
title Serum protein signature of coronary artery disease in type 2 diabetes mellitus
title_full Serum protein signature of coronary artery disease in type 2 diabetes mellitus
title_fullStr Serum protein signature of coronary artery disease in type 2 diabetes mellitus
title_full_unstemmed Serum protein signature of coronary artery disease in type 2 diabetes mellitus
title_short Serum protein signature of coronary artery disease in type 2 diabetes mellitus
title_sort serum protein signature of coronary artery disease in type 2 diabetes mellitus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345069/
https://www.ncbi.nlm.nih.gov/pubmed/30674322
http://dx.doi.org/10.1186/s12967-018-1755-5
work_keys_str_mv AT adelaramu serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus
AT reddypodduturunaveenchander serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus
AT ghoshtarinishankar serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus
AT aggarwalsuruchi serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus
AT yadavamitkumar serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus
AT dasbhabatosh serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus
AT banerjeesanjayk serumproteinsignatureofcoronaryarterydiseaseintype2diabetesmellitus